Frédérique Klupsch

Author

Frédérique Klupsch

Also Known As

Frederique Klupsch, Fredérique Klupsch, Fréderique Klupsch, Frédérique Klupsch, Klupsch, F., Klupsch, Fredérique, Klupsch, Frédérique

Publications

444

Citations

H-Index

Concepts

All Affiliations

Université de Lille Inserm Institut de Chimie Lille Inflammation Research International Center Université Lille Nord de France

About

Frédérique Klupsch is an author at Université de Lille specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	171
2	Biochemistry	6	6	146
3	Natural Sciences	4	4	104
4	Engineering	1	1	11
5	Biomolecular Engineering	1	1	11

Frédérique Klupsch

Publications

421

Citations

H-Index

Page 1

	Year	Citations
Comparative pharmacological studies of melatonin receptors: mt1, mt2 and mt3/qr2. tissue distribution of mt3/qr2 11Abbreviations: MCA-NAT, methoxy-carbonylamino-N-acetyltrypta- mine, 2-[125I]-I-MCA-NAT, 2-[125I]-iodomethoxy-carbonylamino-N-acetyltryptamine; 2-IbMT, 2-iodo-N-butanoyl-5-methoxytryptamine; 4-P-PDOT, 4-phenyl-2-propionamido-tetraline; DH97, N-pentanoyl-2-benzyltryptamine; S20760, 5-methoxy-N-cyclopropanoyl-tryptamine; S24635, N-[2-(5-carbamoylbenzofuran-3-yl)ethyl]-acetamide; S25726, N-methyl-(3-{2-[(cyclopropylcarbonyl)-amino]ethyl}benzo[b]furan-5-yl)carbamate; S26553, N-methyl-{1-[2-(acetylamino)ethyl]-naphthalen-7-yl}carbamate. Olivier Nosjean, Jean‐Paul Nicolas, Frédérique Klupsch, Biochemical Pharmacology	2001	187
New benzo[5,6]pyrrolizino[1,2- b ]quinolines as cytotoxic agents Aurore Perzyna, Frédérique Klupsch, Raymond Houssin, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryNew BenzoBiochemistryMedicineNatural Sciences	2004	42
2,6-Diphenylthiazolo[3,2-b][1,2,4]triazoles as telomeric G-quadruplex stabilizers Jamal El Bakali, Frédérique Klupsch, Aurore Guédin, Bioorganic & Medicinal Chemistry Letters Telomeric G-quadruplex StabilizersHeterocyclicHeterocycle Chemistry	2009	27
Conformational Restriction Leading to a Selective CB<sub>2</sub> Cannabinoid Receptor Agonist Orally Active Against Colitis Jamal El Bakali, Giulio G. Muccioli, Mathilde Body–Malapel, ACS Medicinal Chemistry Letters -One ScaffoldGastrointestinal PharmacologyImmunologyGastroenterologyPharmacotherapy	2014	26
Pyrazolones as inhibitors of immune checkpoint blocking the PD-1/PD-L1 interaction Raphaël Le Biannic, Romain Magnez, Frédérique Klupsch, European Journal of Medicinal Chemistry Immune CheckpointMedicineImmunologyTumor ImmunityImmune Checkpoint Inhibitor	2022	25
4-Oxo-1,4-dihydropyridines as Selective CB<sub>2</sub> Cannabinoid Receptor Ligands Part 2: Discovery of New Agonists Endowed with Protective Effect Against Experimental Colitis Jamal El Bakali, Pauline Gilleron, Mathilde Body–Malapel, Journal of Medicinal Chemistry Cannabis UseMolecular PharmacologyNew Agonists EndowedBiochemistryGastrointestinal Pharmacology	2012	24
Design, solid-phase synthesis, and biological evaluation of novel 1,5-diarylpyrrole-3-carboxamides as carbonic anhydrase IX inhibitors Sébastien Gluszok, Raphaël Frédérick, Catherine Foulon, Bioorganic & Medicinal Chemistry Medicinal ChemistrySolid-phase SynthesisBiochemistryNatural SciencesMedicine	2010	20
Development of novel oxazolo[5,4-d]pyrimidines as competitive CB2 neutral antagonists based on scaffold hopping Wei Tuo, Mélanie Bollier, Natascha Leleu‐Chavain, European Journal of Medicinal Chemistry Combinatorial ChemistryScaffold HoppingBiochemistryMedicinePharmacological Agent	2018	18
Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3 Mohamed Ettaoussi, Basile Pérès, Frédérique Klupsch, Bioorganic & Medicinal Chemistry New LigandsCombinatorial ChemistryBiochemistryMedicineNatural Sciences	2008	16
Major Metabolites of Zolpidem: Expeditious Synthesis and Mass Spectra Frédérique Klupsch, Raymond Houssin, Luc Humbert, Chemical and Pharmaceutical Bulletin	2006	14

Page 1